Financials TMC Life Sciences

Equities

TMCLIFE

MYQ0101OO004

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA 18:00:00 2024-04-25 EDT 5-day change 1st Jan Change
0.695 MYR +0.72% Intraday chart for TMC Life Sciences +2.96% -2.80%

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 1,242 1,263 862.2 1,089 888.4 1,045
Enterprise Value (EV) 1 1,039 1,083 812.9 1,122 955.7 1,095
P/E ratio 46.1 x 60.4 x 54.3 x 53.9 x 21.5 x 26.7 x
Yield 0.26% 0.28% 0.41% 0.35% 0.54% 0.7%
Capitalization / Revenue 7.34 x 6.48 x 4.68 x 5.42 x 3.64 x 3.35 x
EV / Revenue 6.14 x 5.56 x 4.42 x 5.58 x 3.92 x 3.52 x
EV / EBITDA 28.2 x 26.2 x 29.3 x 31.1 x 21.4 x 16 x
EV / FCF -126 x -65.2 x - -17 x -22 x -187 x
FCF Yield -0.79% -1.53% - -5.89% -4.55% -0.54%
Price to Book 1.68 x 1.66 x 1.12 x 1.38 x 1.07 x 1.21 x
Nbr of stocks (in thousands) 1,736,385 1,741,882 1,741,882 1,741,882 1,741,882 1,741,882
Reference price 2 0.7150 0.7250 0.4950 0.6250 0.5100 0.6000
Announcement Date 18-12-24 19-12-18 20-08-25 21-08-24 22-08-23 23-08-22
1MYR in Million2MYR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 169 195 184.1 201 243.8 311.6
EBITDA 1 36.81 41.31 27.78 36.02 44.63 68.43
EBIT 1 24.31 30.84 18.33 25.84 32.1 47.04
Operating Margin 14.38% 15.82% 9.96% 12.85% 13.17% 15.1%
Earnings before Tax (EBT) 1 33.1 38.15 22.1 27.67 32.18 40.89
Net income 1 27.8 20.92 15.93 20.25 41.39 39.26
Net margin 16.44% 10.73% 8.65% 10.08% 16.98% 12.6%
EPS 2 0.0155 0.0120 0.009120 0.0116 0.0238 0.0225
Free Cash Flow 1 -8.212 -16.6 - -66.11 -43.5 -5.864
FCF margin -4.86% -8.52% - -32.89% -17.84% -1.88%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 0.001830 0.002013 0.002014 0.002215 0.002763 0.004199
Announcement Date 18-12-24 19-12-18 20-08-25 21-08-24 22-08-23 23-08-22
1MYR in Million2MYR
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - 33.4 67.3 50.4
Net Cash position 1 203 180 49.4 - - -
Leverage (Debt/EBITDA) - - - 0.9284 x 1.508 x 0.7361 x
Free Cash Flow 1 -8.21 -16.6 - -66.1 -43.5 -5.86
ROE (net income / shareholders' equity) 3.82% 2.78% - 2.59% 5.12% 4.65%
ROA (Net income/ Total Assets) 1.93% 2.34% - 1.61% 1.83% 2.55%
Assets 1 1,437 895.5 - 1,261 2,262 1,542
Book Value Per Share 2 0.4300 0.4400 0.4400 0.4500 0.4700 0.4900
Cash Flow per Share 2 0.1200 0.1000 0.0800 0.0800 0.0800 0.1000
Capex 1 34.9 61.2 164 103 67.7 32
Capex / Sales 20.67% 31.41% 88.88% 51.05% 27.77% 10.26%
Announcement Date 18-12-24 19-12-18 20-08-25 21-08-24 22-08-23 23-08-22
1MYR in Million2MYR
Estimates
  1. Stock Market
  2. Equities
  3. TMCLIFE Stock
  4. Financials TMC Life Sciences